Literature DB >> 9846514

Adult living donor liver transplantation using a right hepatic lobe.

M E Wachs1, T E Bak, F M Karrer, G T Everson, R Shrestha, T E Trouillot, M S Mandell, T G Steinberg, I Kam.   

Abstract

BACKGROUND: Living donor liver transplantation has gained wide acceptance as an alternative for children with end-stage liver disease. The standard left lateral segment used in this operation does not provide adequate parenchymal mass to broaden its application to larger children or adults.
METHODS: We report two cases of adult to adult living donor liver transplantation using a right hepatic lobe in patients with chronic liver disease.
RESULTS: Both recipients experienced excellent initial graft function and have normal liver function 4 and 9 months postoperatively. Both donors are alive and well and returned to normal life 4 weeks postoperatively.
CONCLUSIONS: Our initial experience suggests that this technique is a safe and reliable option for adults with chronic end-stage liver disease. A conservative application of this procedure in the adult population could significantly reduce the mortality on the adult waiting list.

Entities:  

Mesh:

Year:  1998        PMID: 9846514     DOI: 10.1097/00007890-199811270-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  42 in total

Review 1.  Themes of liver transplantation.

Authors:  Thomas E Starzl; John J Fung
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

Review 2.  The unfinished legacy of liver transplantation: emphasis on immunology.

Authors:  Thomas E Starzl; Fadi G Lakkis
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

4.  Risk factors of biliary intervention by imaging after living donor liver transplantation.

Authors:  Soon Kyu Lee; Jong Young Choi; Dong Myung Yeo; Young Joon Lee; Seung Kew Yoon; Si Hyun Bae; Jeong Won Jang; Hee Yeon Kim; Dong Goo Kim; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

5.  Pattern of branching of the left portal vein: an anatomo-radiological study.

Authors:  Veronica Macchi; Andrea Porzionato; Aldo Morra; Giovanni Franco Zanon; Raffaele De Caro
Journal:  Surg Radiol Anat       Date:  2015-02-03       Impact factor: 1.246

6.  Twenty years of Milan criteria and live-donor liver transplantation in the US: a contrast in transparency, regulation, and expectation.

Authors:  David C Cronin; Timothy M Cronin
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

7.  Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases.

Authors:  Dieter C Broering; Christian Wilms; Pamela Bok; Lutz Fischer; Lars Mueller; Christian Hillert; Christian Lenk; Jong-Sun Kim; Martina Sterneck; Karl-Heinz Schulz; Gerrit Krupski; Axel Nierhaus; Detlef Ameis; Martin Burdelski; Xavier Rogiers
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

8.  Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.

Authors:  Satoru Todo; Hiroyuki Furukawa
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

9.  Defining long-term outcomes with living donor liver transplantation in North America.

Authors:  Kim M Olthoff; Abigail R Smith; Michael Abecassis; Talia Baker; Jean C Emond; Carl L Berg; Charlotte A Beil; James R Burton; Robert A Fisher; Chris E Freise; Brenda W Gillespie; David R Grant; Abhinav Humar; Igal Kam; Robert M Merion; Elizabeth A Pomfret; Benjamin Samstein; Abraham Shaked
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

10.  Analysis of complications in hepatic right lobe living donors.

Authors:  Ayman Azzam; Kinji Uryuhara; Ito Taka; Yasutsugu Takada; Hiroto Egawa; Koichi Tanaka
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.